{"id":4785,"date":"2023-08-07T01:46:36","date_gmt":"2023-08-06T23:46:36","guid":{"rendered":"https:\/\/www.institutmacula.com\/?p=4785"},"modified":"2023-08-07T01:48:07","modified_gmt":"2023-08-06T23:48:07","slug":"el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion","status":"publish","type":"post","link":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/","title":{"rendered":"El tratamiento pionero para la DMAE atr\u00f3fica, en el foco de los medios de comunicaci\u00f3n"},"content":{"rendered":"\n<p>El inter\u00e9s que genera el f\u00e1rmaco aprobado este a\u00f1o por la Foods and Drugs Administration (FDA) norteamericana para el tratamiento de la DMAE atr\u00f3fica ha atra\u00eddo las miradas de los medios de nuestro entorno. El car\u00e1cter pionero de este f\u00e1rmaco (que ha demostrado efectividad en una patolog\u00eda que hasta ahora no ten\u00eda tratamiento) ha despertado el inter\u00e9s de los medios generalistas de todo el Estado, y muchos han querido recoger las impresiones del Prof. Jordi Mon\u00e9s. El director del Instituto de la M\u00e1cula ha participado en el desarrollo del f\u00e1rmaco, y es por ello que es una fuente de primera mano para explicarlo y valorar su dimensi\u00f3n.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.elperiodico.com\/es\/sanidad\/20230602\/farmaco-syfovre-ceguera-edad-degeneracion-macular-88187862\">El Peri\u00f3dico de Catalunya<\/a>\u00a0dedic\u00f3 una p\u00e1gina en la edici\u00f3n impresa \u2014accesible tambi\u00e9n para los suscriptores de la edici\u00f3n digital\u2014 y se hizo eco tambi\u00e9n en las p\u00e1ginas de opini\u00f3n, en el sumario, en las que el Dr. Mon\u00e9s apareci\u00f3 con el color verde \u2014remarcando as\u00ed el car\u00e1cter positivo de la noticia.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"380\" src=\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/semafor-ES_-1024x380.jpg\" alt=\"\" class=\"wp-image-4786\" srcset=\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/semafor-ES_-1024x380.jpg 1024w, https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/semafor-ES_-300x111.jpg 300w, https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/semafor-ES_-768x285.jpg 768w, https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/semafor-ES_-1536x570.jpg 1536w, https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/semafor-ES_-2048x760.jpg 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>Tambi\u00e9n&nbsp;<a href=\"https:\/\/www.eldiario.es\/sociedad\/inyeccion-ojo-frenar-perdida-vision-relacionada-edad_1_10288230.html\">eldiario.es<\/a>&nbsp;quiso contrastar con el Prof. Mon\u00e9s la dimensi\u00f3n del nuevo f\u00e1rmaco. En el \u00e1mbito radiof\u00f3nico,&nbsp;<a href=\"https:\/\/www.rtve.es\/play\/audios\/serveis-informatius-radio-4\/primers-farmacs-contra-ceguera-per-dmae\/6946263\/\">R\u00e0dio Nacional de Espa\u00f1a<\/a>,&nbsp;<a href=\"https:\/\/www.rac1.cat\/salut\/20230710\/111034\/primers-farmacs-contra-principal-causa-ceguesa-gent-gran-signatura-catalana.html?utm_medium=social&amp;utm_source=twitter&amp;utm_content=salut\">RAC1<\/a>, Catalunya R\u00e0dio y R\u00e0dio Estel se han hecho eco de la aparici\u00f3n del tratamiento. Y en el \u00e1mbito televisivo, tanto la televisi\u00f3n barcelonesa&nbsp;<a href=\"https:\/\/beteve.cat\/ciencia-i-tecnologia\/barceloni-clau-estudi-primer-farmac-frena-ceguesa-degeneracio-macular\/\">betev\u00e9<\/a>&nbsp;como la balear IB3 y la catalana TV3 han cubierto la noticia.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El inter\u00e9s que genera el f\u00e1rmaco aprobado este a\u00f1o por la Foods and Drugs Administration (FDA) norteamericana para el tratamiento de la DMAE atr\u00f3fica ha atra\u00eddo las miradas de los medios de nuestro entorno. El car\u00e1cter pionero de este f\u00e1rmaco (que ha demostrado efectividad en una patolog\u00eda que hasta ahora no ten\u00eda tratamiento) ha despertado [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":4776,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23],"tags":[],"class_list":["post-4785","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>El tratamiento pionero para la DMAE atr\u00f3fica, en el foco de los medios de comunicaci\u00f3n - Institut de la M\u00e0cula<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El tratamiento pionero para la DMAE atr\u00f3fica, en el foco de los medios de comunicaci\u00f3n - Institut de la M\u00e0cula\" \/>\n<meta property=\"og:description\" content=\"El inter\u00e9s que genera el f\u00e1rmaco aprobado este a\u00f1o por la Foods and Drugs Administration (FDA) norteamericana para el tratamiento de la DMAE atr\u00f3fica ha atra\u00eddo las miradas de los medios de nuestro entorno. El car\u00e1cter pionero de este f\u00e1rmaco (que ha demostrado efectividad en una patolog\u00eda que hasta ahora no ten\u00eda tratamiento) ha despertado [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/\" \/>\n<meta property=\"og:site_name\" content=\"Institut de la M\u00e0cula\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-06T23:46:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-06T23:48:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/clipping.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"maties\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"maties\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/\"},\"author\":{\"name\":\"maties\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#\/schema\/person\/7132d3f447c8d1fc4507e3c9f72dcfaa\"},\"headline\":\"El tratamiento pionero para la DMAE atr\u00f3fica, en el foco de los medios de comunicaci\u00f3n\",\"datePublished\":\"2023-08-06T23:46:36+00:00\",\"dateModified\":\"2023-08-06T23:48:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/\"},\"wordCount\":276,\"publisher\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/clipping.jpg\",\"articleSection\":[\"Home\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/\",\"url\":\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/\",\"name\":\"El tratamiento pionero para la DMAE atr\u00f3fica, en el foco de los medios de comunicaci\u00f3n - Institut de la M\u00e0cula\",\"isPartOf\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/clipping.jpg\",\"datePublished\":\"2023-08-06T23:46:36+00:00\",\"dateModified\":\"2023-08-06T23:48:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#primaryimage\",\"url\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/clipping.jpg\",\"contentUrl\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/clipping.jpg\",\"width\":1024,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/www.institutmacula.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El tratamiento pionero para la DMAE atr\u00f3fica, en el foco de los medios de comunicaci\u00f3n\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#website\",\"url\":\"https:\/\/www.institutmacula.com\/es\/\",\"name\":\"Institut de la M\u00e0cula\",\"description\":\"Innovating Eye Care\",\"publisher\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.institutmacula.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#organization\",\"name\":\"Institut de la M\u00e0cula\",\"url\":\"https:\/\/www.institutmacula.com\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/02\/logo-Institut-de-la-Macula-24.png\",\"contentUrl\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/02\/logo-Institut-de-la-Macula-24.png\",\"width\":300,\"height\":120,\"caption\":\"Institut de la M\u00e0cula\"},\"image\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#\/schema\/person\/7132d3f447c8d1fc4507e3c9f72dcfaa\",\"name\":\"maties\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El tratamiento pionero para la DMAE atr\u00f3fica, en el foco de los medios de comunicaci\u00f3n - Institut de la M\u00e0cula","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/","og_locale":"es_ES","og_type":"article","og_title":"El tratamiento pionero para la DMAE atr\u00f3fica, en el foco de los medios de comunicaci\u00f3n - Institut de la M\u00e0cula","og_description":"El inter\u00e9s que genera el f\u00e1rmaco aprobado este a\u00f1o por la Foods and Drugs Administration (FDA) norteamericana para el tratamiento de la DMAE atr\u00f3fica ha atra\u00eddo las miradas de los medios de nuestro entorno. El car\u00e1cter pionero de este f\u00e1rmaco (que ha demostrado efectividad en una patolog\u00eda que hasta ahora no ten\u00eda tratamiento) ha despertado [&hellip;]","og_url":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/","og_site_name":"Institut de la M\u00e0cula","article_published_time":"2023-08-06T23:46:36+00:00","article_modified_time":"2023-08-06T23:48:07+00:00","og_image":[{"width":1024,"height":600,"url":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/clipping.jpg","type":"image\/jpeg"}],"author":"maties","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"maties","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#article","isPartOf":{"@id":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/"},"author":{"name":"maties","@id":"https:\/\/www.institutmacula.com\/es\/#\/schema\/person\/7132d3f447c8d1fc4507e3c9f72dcfaa"},"headline":"El tratamiento pionero para la DMAE atr\u00f3fica, en el foco de los medios de comunicaci\u00f3n","datePublished":"2023-08-06T23:46:36+00:00","dateModified":"2023-08-06T23:48:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/"},"wordCount":276,"publisher":{"@id":"https:\/\/www.institutmacula.com\/es\/#organization"},"image":{"@id":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#primaryimage"},"thumbnailUrl":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/clipping.jpg","articleSection":["Home"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/","url":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/","name":"El tratamiento pionero para la DMAE atr\u00f3fica, en el foco de los medios de comunicaci\u00f3n - Institut de la M\u00e0cula","isPartOf":{"@id":"https:\/\/www.institutmacula.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#primaryimage"},"image":{"@id":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#primaryimage"},"thumbnailUrl":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/clipping.jpg","datePublished":"2023-08-06T23:46:36+00:00","dateModified":"2023-08-06T23:48:07+00:00","breadcrumb":{"@id":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#primaryimage","url":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/clipping.jpg","contentUrl":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2023\/08\/clipping.jpg","width":1024,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.institutmacula.com\/es\/el-tratamiento-pionero-para-la-dmae-atrofica-en-el-foco-de-los-medios-de-comunicacion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/www.institutmacula.com\/es\/"},{"@type":"ListItem","position":2,"name":"El tratamiento pionero para la DMAE atr\u00f3fica, en el foco de los medios de comunicaci\u00f3n"}]},{"@type":"WebSite","@id":"https:\/\/www.institutmacula.com\/es\/#website","url":"https:\/\/www.institutmacula.com\/es\/","name":"Institut de la M\u00e0cula","description":"Innovating Eye Care","publisher":{"@id":"https:\/\/www.institutmacula.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.institutmacula.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.institutmacula.com\/es\/#organization","name":"Institut de la M\u00e0cula","url":"https:\/\/www.institutmacula.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.institutmacula.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/02\/logo-Institut-de-la-Macula-24.png","contentUrl":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/02\/logo-Institut-de-la-Macula-24.png","width":300,"height":120,"caption":"Institut de la M\u00e0cula"},"image":{"@id":"https:\/\/www.institutmacula.com\/es\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.institutmacula.com\/es\/#\/schema\/person\/7132d3f447c8d1fc4507e3c9f72dcfaa","name":"maties"}]}},"_links":{"self":[{"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/posts\/4785","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/comments?post=4785"}],"version-history":[{"count":2,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/posts\/4785\/revisions"}],"predecessor-version":[{"id":4789,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/posts\/4785\/revisions\/4789"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/media\/4776"}],"wp:attachment":[{"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/media?parent=4785"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/categories?post=4785"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/tags?post=4785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}